Abiopharma

Fortrea 與 Emery Pharma 宣佈開展戰略合作，使用利福平 (Rifampin) 開展符合 FDA 要求的藥物相互作用試驗

Fortrea und Emery Pharma kündigen strategische Zusammenarbeit zur Durchführung FDA-konformer Arzneimittelwechselwirkungsstudien mit Rifampin an

Fortrea dan Emery Pharma Umumkan Kerjasama Strategik untuk Menjalankan Kajian Interaksi Ubat yang Mematuhi Piawaian FDA Menggunakan Rifampin

Fortrea 与 Emery Pharma 宣布战略合作以开展符合 FDA 规范的利福平药物相互作用研究

フォートリア (Fortrea) とエメリー・ファーマ (Emery Pharma)、リファンピンを用いたFDA準拠の薬物相互作用 (Drug-Drug-Interaction、DDI) 試験を提供するための戦略的提携を発表

Fortrea & Emery Pharma Anunciam Colaboração Estratégica para Fornecer Estudos de Interação Medicamentosa Usando Rifampicina em Conformidade com o FDA

Fortrea ו-Emery Pharma מכריזות על שיתוף פעולה אסטרטגי לביצוע מחקרי אינטראקציה בין תרופות באמצעות ריפמפיצין, בהתאם לתקני ה-FDA

Fortrea et Emery Pharma annoncent une collaboration stratégique visant à mener des études sur les interactions médicamenteuses répondant aux normes de la FDA en utilisant la rifampicine

Fortrea y Emery Pharma anuncian colaboración estratégica para realizar estudios de interacción fármaco-fármaco que cumplan con la FDA utilizando rifampicina

Fortrea & Emery Pharma Umumkan Kolaborasi Strategis untuk Melakukan Studi Interaksi Obat-Obat yang Sesuai Peraturan FDA dengan Menggunakan Rifampin

New Form 144 - Cencora, Inc. Filed: 2025-06-24 AccNo: 0001959173-25-004261 Size: 6 KB

New Form 8-K - ACURA PHARMACEUTICALS, INC Filed: 2025-06-24 AccNo: 0001104659-25-061980 Size: 243 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant …

New Form 8-K - Dogwood Therapeutics, Inc. Filed: 2025-06-24 AccNo: 0001558370-25-008817 Size: 327 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and …

New Form 4 - MESA LABORATORIES INC /CO/ Filed: 2025-06-24 AccNo: 0001228924-25-000016 Size: 8 KB

New Form 6-K - GSK plc Filed: 2025-06-24 AccNo: 0001654954-25-007326 Size: 16 KB